Shares of Intellia Therapeutics, Inc. (NTLA) have gained 14.9% over the past four weeks to close the last trading session at $7.88, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $40.08 indicates a potential upside of 408.6%.The mean estimate comprises 25 short-term price targets with a standard deviation of $26.66. While the lowest estimate of $9 indicates a 14.2% increase fro ...

Shares of Enanta Pharmaceuticals (ENTA) have gained 5.1% over the past four weeks to close the last trading session at $5.18, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $15 indicates a potential upside of 189.6%.The mean estimate comprises six short-term price targets with a standard deviation of $7.27. While the lowest estimate of $5 indicates a 3.5% decline from the curre ...

MoonLake Immunotherapeutics (MLTX) closed the last trading session at $36.99, gaining 0.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $76.43 indicates a 106.6% upside potential.The mean estimate comprises 14 short-term price targets with a standard deviation of $13.12. While the lowest estimate of $55 indicates a 48.7% increase from the current price level, the most optimistic ...

Shares of NovoCure (NVCR) have gained 8% over the past four weeks to close the last trading session at $17.10, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $35.14 indicates a potential upside of 105.5%.The mean estimate comprises seven short-term price targets with a standard deviation of $6.74. While the lowest estimate of $27 indicates a 57.9% increase from the current pric ...

Honda (HMC) reported earnings of 18 cents per share for fourth-quarter fiscal 2025, missing the Zacks Consensus Estimate of 72 cents. The bottom line also declined from the year-ago profit of 99 cents per share. Quarterly revenues totaled $35.1 billion, lagging the Zacks Consensus Estimate of $35.6 billion as well as the year-ago period figure of $36.5 billion.HMC currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.Segmental Highlights Fo ...

Toyota (TM) reported fiscal fourth-quarter 2025 earnings per share of $3.39, which surpassed the Zacks Consensus Estimate of $2.92 but declined from the year-ago quarter’s earnings of $4.99. Consolidated revenues came in at $81.09 billion, which beat the consensus mark of $78.47 billion and also grew from $74.56 billion in the year-ago quarter.  Toyota had cash and cash equivalents (non-financial services businesses) of ¥6.09 trillion ($41.75 billion) as of March 31, 2025. Long-term debt (non-financial serv ...

Novo Nordisk (NVO) announced a significant partnership with Septerna (SEPN) , a U.S.-based biotech company, valued at up to $2.2 billion, to tap the growing obesity treatment market.  Following the announcement, SEPN shares jumped 51%, while NVO shares gained a little 1.6%. This put the spotlight on healthcare ETFs, which could be the best way for investors to tap the opportunity arising from the proposed deal. Investors should keep a close eye on the movement of ETFs like Roundhill GLP-1 & Weight Loss ETF ...

CHONGQING, CHINA - APRIL 26: In this photo illustration, the logo of CVS Health Corporation is ... More displayed on a smartphone screen, with the company's red heart branding visible in the background, on April 26, 2025, in Chongqing, China. (Photo illustration by Cheng Xin/Getty Images)Getty ImagesHealth insurance companies have been in the limelight lately after UnitedHealthcare suspended its guidance for the full year citing higher medical costs. This comes during a challenging time when the CEO Andrew ...

Shares of Lamar Advertising (NASDAQ: LAMR ) have been a mediocre performer over the past year, essentially treading water. While its core business has done well, pressures on national advertising and higher-for-longer interest rates have been headwinds for valuation. Still, theOver fifteen years of experience making contrarian bets based on my macro view and stock-specific turnaround stories to garner outsized returns with a favorable risk/reward profile. If you want me to cover a specific stock or have a q ...

Animated Specials to Begin Debuting This Year and Include Pup-tacular Holiday Event Share it: @Nickelodeon @NickelodeonFamily @PAWPatrol #PAWPatrol Click HERE for assets.BURBANK, Calif., May 15, 2025 /PRNewswire/ -- Nickelodeon and Spin Master Entertainment are doubling down on the top-rated preschool powerhouse PAW Patrol, with a brand-new slate of five original hour-long specials. Each of the animated specials center on a different pup, with the first featuring jungle rescuer Tracker set to premiere this ...